Vancouver, British Columbia, July 21, 2021 (Globe Newsweiser) – Other food handles INC. (Baby V) (Baby) (0YL.F) (“other”) Or “Company”) Plant-based infant, toddler and infant nutrition company is pleased to announce two strategic increases for the company’s executive team:

Mr. Simon Sunder as VP Global Medical Marketing and Scientific Affairs

The company employs Simon Soundson as VP Global Medical Marketing and Scientific Affairs.

With this capacity, Mr. Saunders will lead the company’s global medical marketing, clinical and regulatory affairs around the world to promote Elsin’s global reach in those areas.

After graduating from university, Mr. Sounders entered the healthcare industry with 35 years of business experience, compensating for primary care, specialized pharmaceutical and dietary products, and accessing out-of-pocket channels (baby formula, medical nutrition, out-of-pocket supplement). , And sports nutrition).

Throughout his career, he has served on the board of the Powder and Asphalt Liquid Factory, playing a leading role in sales, marketing, national and public administration.

A.D. Prior to his appointment as an independent consultant in 2018, Simon worked in Abbott Laboratories for 25 years.

Mr. Mike Glick, GM and VPL North America

In this capacity, Mr. Glick will lead the US sub-expansion, primarily in medical marketing retail and operations. Mike also took charge of the business when he moved to Canada. Mike joined the ACC-sponsored start-up health program called OFFOR Health, which helped fund the series A and fund the first $ 5,000 in revenue and group size.

Mike was previously with Willie Sales and Marketing for SpoonfulOne with Silicon Valley launch. There, he led new product launches, digital marketing and e-commerce, building and managing the medical sales force by calling pediatricians.

Prior to that, Mike spent 10+ years with Abbott in various business roles in the United States and around the world. In Abbott, as Director General of Baby Nutrition, he has worked primarily in the field of infant nutrition, with products such as Neosure, Symilac, Pediaasare, and Pediaia.

We are thrilled to have Mike and Simon added to the company. They have decades of experience in infant nutrition, so they need to move on to the next stage of development. ”

About Other Nutrition Development Holdings Inc.

Else Nutrition GH Limited is an Israeli-based food and nutrition company that specializes in the development of fresh, nutritious and plant-based food products for infants, toddlers, children and adults. Its revolutionary, plant-based, non-soy-based formula is an alternative to pure milk. Milan Nutrition (formerly INDI) won the 2017 Best Health and Nutrition Solutions Award at the International Food Innovation Conference in Milan. Another herbal supplement for teens has recently been ranked # 1 on the Amazon for baby and toddler formula. Els Balanced Holdings, a trademark listed on the TSX Venture Exchange, is listed on the US OTC Markets QX Board under the trademark BABYF and the Frankfurt Exchange under the 0YL mark. . Elsie executives include leaders from infant nutrition companies. Many members of the Elsie Advisory Board have held executive positions in companies such as Mead Johnson, Abbott Nutrition, Plum Organic and Baby Nutrition Associations, and some currently hold various positions in various medical centers and educational institutions such as Boston Children’s Hospital. At Harvard Medical School in the United States, Tel Aviv University, Israel Schneider Pediatric Center, Rambam Medical Center and Technology, Israel and University Hospital Brussels, Belgium Pediatrics.

For more information visit: elsenutrition.com Or @elsenutrition on Facebook and Instagram.

Media contact
Erin Jundef
Bright PR
erinj@brilliantpr.com

For more information
Ms. Hamutal Isaac, CEO, Co-Founder and Director
ELSE Nutrition Holdings Inc.
A: hamutaly@elsenutrition.com
Page: +972 (0) 3-6445095

The Director of Other Nutrition, Mr. Sochi Arwar
A: sokhiep@elsenutrition.com
Pp. 604-603-7787

TSX Venture Exchange

TSX Venture Exchange or its regulatory services provider (as defined in the TSX Venture Exchange Policies) does not accept responsibility for the accuracy or completeness of this release.

Caution about future statements

This press release contains statements that may be “forward-looking statements” in the translation of applicable safety laws. Future expressions are usually identified by words such as “will” or similar expressions. Future statements in this press release include statements related to the company’s expected financial statements. Such forward-looking statements are believed to be appropriate for the administration’s current assumptions, beliefs and assumptions, as well as other factors based on current administration’s understanding of the current situation and future prospects. No proof can be given that this is true. The forward-looking statements made in this press release, the termination or failure of the supply chain due to COVID 19 and the assumption that the production, brokerage and supply logistics agreement with the Company will not be terminated. Accurate results may differ from those described or listed in future statements by reviews, beliefs and assumptions. From the date of this press release, readers have been warned not to place unreasonable reliance on any future statements of government officials. The Company denies that it is under no obligation to update or revise any forecasts on the basis of new information, upcoming events or other reasons, except in accordance with the law.

Photo of this ad is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/a5b7b0b6-1a86-4212-bc20-a34594cc0720

.